Therapeutic hotline: An alternative adjuvant treatment after ear keloid excision using a custom-made methyl methacrylate stent.
The efficacy of most pressure devices developed for treatment of ear keloids is limited by the insufficient control of the applied pressure, sometimes causing pain and repeated bleeding with a subsequently increased risk of infections and cosmetic problems. The present study aims to describe the efficacy of the custom-made methyl methacrylate stent in patients that were surgically treated for ear keloids and afterward underwent pressure therapy. The recurrence rate of the ear keloids was evaluated after at least 12 months. Adjuvant treatment with the methyl methacrylate stent resulted in an 83% success rate in our experience with 23 patients that completed the intended therapeutic duration of 18 months. No cases of severe complications were seen during or after the treatment. Furthermore, all the items of the Patient and Observer Scar Assessment Scale resulted in a statistically significant improvement of the scar (p < 0.05). Postoperative pressure therapy with the custom-made methyl methacrylate stent seems efficacious, safe, and is usable for keloids of both the helix and the earlobe.
Department of Plastic and Reconstructive Surgery, VU University Medical Center, Amsterdam, the Netherlands.
Daniel J
DJ
Kadouch
Willem M
WM
van der Veer
Babak
B
Mahdavian Delavary
Desiree
D
Kerkdijk
Frank B
FB
Niessen
D000293:Adolescent; D000328:Adult; D003131:Combined Modality Therapy; D004427:Ear Diseases / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D005260:Female; D006801:Humans; D007627:Keloid / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D008297:Male; D020366:Methylmethacrylate; D008875:Middle Aged; D009426:Netherlands; D011312:Pressure; D011474:Prosthesis Design; D012008:Recurrence; D012189:Retrospective Studies; D015607:Stents; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
D020366:Methylmethacrylate